Skip to content

Flavanols and Skin Photo Protection: a Clinical Trial

Flavanols and Skin Photo Protection: a Double Blind Clinical Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01444625
Acronym
CHOCOPO
Enrollment
78
Registered
2011-10-03
Start date
2011-06-30
Completion date
2013-05-31
Last updated
2013-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solar Skin Damage

Keywords

UV radiation, photoprotection, flavanols rich chocolate

Brief summary

As flavanols have antioxidants, anti-inflammatory and anti-DNA damaging effects and may increase microcirculation in skin, the purpose of the study is to investigate the chronic effect of flavanol-rich chocolate as an effective strategy to protect against the harmful effect of ultraviolet (UV) radiation.

Detailed description

Recent data suggested that chronic ingestion of high flavanols cocoa might be a promising agent for dietary photo protection against UV light. Moreover, flavanols-rich cocoa intake has been shown to increase microcirculation in human skin.

Interventions

High-flavanol chocolate, 12 weeks.

OTHERFlavanol-free chocolate

Flavanol-free chocolate, 12 weeks

Sponsors

Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Non-smoking women between the ages of 20 and 65 years. * Normal skin of type I and II as decried by Fitzpatrick classification.

Exclusion criteria

* Pregnancy and breast feeding. * Photo sensibility: history of skin cancers, photosensitizing medication. * Sun bed use or sunbathing in the previous 3 months. * Use of supplements or natural health products (fish oils, coenzyme Q10, garlic, lycopene, beta carotene). * Allergy or intolerance to nuts or chocolate.

Design outcomes

Primary

MeasureTime frame
Change in Minimal erythema dosewithin the first 12 weeks of chocolate intake and 3 weeks later after end of chocolate consumption

Secondary

MeasureTime frame
Change in Skin elasticitywithin the first 12 weeks of chocolate intake and 3 weeks later after end of chocolate consumption
Change in Skin moisturewithin the first 12 weeks of chocolate intake and 3 weeks later after end of chocolate consumption
Change in levels of Vitamin D and polyphenolswithin the first 12 weeks of chocolate intake and 3 weeks later after end of chocolate consumption

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026